COVID-19 and myocardial injury.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Exploring Coronavirus Disease 2019 and Brugada Syndrome.The Journal of innovations in cardiac rhythm management · 2022
   Article
2. Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients.Heliyon · 2022
   Review
3. Editorial commentary: Evidence-based medicine during a pandemic.Trends in cardiovascular medicine · 2021
   Article
4. ECG changes in hospitalised patients with COVID-19 infection.The British journal of cardiology · 2021
   Article
5. Electrocardiographic Findings and Clinical Outcome in Patients with COVID-19 or Other Acute Infectious Respiratory Diseases.Journal of clinical medicine · 2020
   Article
6. Impact of the Pandemic on NonInfected Cardiometabolic Patients: A Survey in Countries of Latin America-Rationale and Design of the CorCOVID LATAM Study.CJC open · 2020
   Article

Corrections and comments

• Comment on
  Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as